0 Évaluations
ID

12862

Description

A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056); ODM derived from: https://clinicaltrials.gov/show/NCT00473889

Lien

https://clinicaltrials.gov/show/NCT00473889

Mots-clés

Versions (1)
  1. 03/01/2016 03/01/2016 -
Téléchargé le

3 janvier 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889

    Anglais

    Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889

    1 Formulaires  
    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    males and females at least 18 years of age who have confirmed diagnosis of non-small cell lung cancer
    Description

    age; non-small cell lung cancer

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0001779
    UMLS CUI [2]
    C0007131
    patients with no systemic prior systemic treatment for lung cancer except patients at least 12 months from prior adjuvant therapy
    Description

    therapy systemic lung cancer

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0087111
    UMLS CUI [1,2]
    C0205373
    UMLS CUI [1,3]
    C0242379
    adequate bone marrow,kidney and liver function
    Description

    organ function adequate; liver function

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0678852
    UMLS CUI [1,2]
    C0205411
    UMLS CUI [2]
    C0232741
    must be recovered and at least 4 weeks from major surgery or radiation
    Description

    major surgery; radiation

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0679637
    UMLS CUI [2]
    C0851346
    ecog (eastern cooperative oncology group) performance status of 0 or 1
    Description

    ecog

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1520224
    men and women must agree to use birth control during the study
    Description

    contraception status

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0420837
    women able to have children must have a negative pregnancy test 14 days before study enrollment
    Description

    negative pregnancy test

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0427780
    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    patients with prior treatment with other investigational agents less than 4 weeks before study enrollment
    Description

    investigational agents

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1875319
    pregnant or nursing female patients
    Description

    pregnancy; lactating

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0032961
    UMLS CUI [1,2]
    C0006147
    patients who are hiv positive
    Description

    hiv positive

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019699
    patients who have hepatitis a, b, or c
    Description

    hepatitis

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0019158
    patients unable to take study medication by mouth
    Description

    Oral Route of Drug administration

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C1527415
    patients with untreated brain cancer
    Description

    brain cancer

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0153633
    patient eligible for treatment with bevacizumab and for whom bevacizumab is available
    Description

    bevacizumab

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0796392
    Retour au début de la page

    Similar models

    Eligibility Stage IIIB or IV Non-Small Cell Lung Cancer NCT00473889

    1 Formulaires
    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    C1512693 (UMLS CUI)
    age; non-small cell lung cancer
    Item
    males and females at least 18 years of age who have confirmed diagnosis of non-small cell lung cancer
    boolean
    C0001779 (UMLS CUI [1])
    C0007131 (UMLS CUI [2])
    therapy systemic lung cancer
    Item
    patients with no systemic prior systemic treatment for lung cancer except patients at least 12 months from prior adjuvant therapy
    boolean
    C0087111 (UMLS CUI [1,1])
    C0205373 (UMLS CUI [1,2])
    C0242379 (UMLS CUI [1,3])
    organ function adequate; liver function
    Item
    adequate bone marrow,kidney and liver function
    boolean
    C0678852 (UMLS CUI [1,1])
    C0205411 (UMLS CUI [1,2])
    C0232741 (UMLS CUI [2])
    major surgery; radiation
    Item
    must be recovered and at least 4 weeks from major surgery or radiation
    boolean
    C0679637 (UMLS CUI [1])
    C0851346 (UMLS CUI [2])
    ecog
    Item
    ecog (eastern cooperative oncology group) performance status of 0 or 1
    boolean
    C1520224 (UMLS CUI [1])
    contraception status
    Item
    men and women must agree to use birth control during the study
    boolean
    C0420837 (UMLS CUI [1])
    negative pregnancy test
    Item
    women able to have children must have a negative pregnancy test 14 days before study enrollment
    boolean
    C0427780 (UMLS CUI [1])
    Item Group
    C0680251 (UMLS CUI)
    investigational agents
    Item
    patients with prior treatment with other investigational agents less than 4 weeks before study enrollment
    boolean
    C1875319 (UMLS CUI [1])
    pregnancy; lactating
    Item
    pregnant or nursing female patients
    boolean
    C0032961 (UMLS CUI [1,1])
    C0006147 (UMLS CUI [1,2])
    hiv positive
    Item
    patients who are hiv positive
    boolean
    C0019699 (UMLS CUI [1])
    hepatitis
    Item
    patients who have hepatitis a, b, or c
    boolean
    C0019158 (UMLS CUI [1])
    Oral Route of Drug administration
    Item
    patients unable to take study medication by mouth
    boolean
    C1527415 (UMLS CUI [1])
    brain cancer
    Item
    patients with untreated brain cancer
    boolean
    C0153633 (UMLS CUI [1])
    bevacizumab
    Item
    patient eligible for treatment with bevacizumab and for whom bevacizumab is available
    boolean
    C0796392 (UMLS CUI [1])
    Retour au début de la page 

    Aide

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial